NCT02460393View on ClinicalTrials.gov

A Trial With Humanized TNFα Monoclonal Antibody Injection by Single Dose and Dose Escalation in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Humanized TNFα monoclonal antibody

"Subcutaneous injection of different doses for healthy people~Subcutaneous injection of different doses in healthy people"

OTHER

placebo

Subcutaneous injection of different doses for healthy people

Trial Locations (1)

100044

Peking University People's Hospital, Beijing

All Listed Sponsors
lead

Shenyang Sunshine Pharmaceutical Co., LTD.

INDUSTRY

NCT02460393 - A Trial With Humanized TNFα Monoclonal Antibody Injection by Single Dose and Dose Escalation in Healthy Subjects | Biotech Hunter | Biotech Hunter